M&T Bank Corp Intellia Therapeutics, Inc. Transaction History

M&T Bank Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$46.59 - $83.68 $344,998 - $619,650	-7,405 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$18.83 - $63.53 $220,819 - $745,016	-11,727 Reduced 61.3%	7,405 $403,000
Q3 2020 Nov 06, 2020	BUY	$17.47 - $24.93 $279 - $398	16 Added 0.08%	19,132 $380,000
Q2 2020 Jul 29, 2020	BUY	$11.14 - $22.87 $4,589 - $9,422	412 Added 2.2%	19,116 $402,000
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $239,224 - $329,564	18,704 New	18,704 $319,000
Q4 2018 Feb 01, 2019	SELL	$11.39 - $27.13 $90,140 - $214,706	-7,914 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$20.02 - $30.79 $158,438 - $243,672	7,914 New	7,914 $216,000
Q1 2018 May 04, 2018	SELL	$19.43 - $34.95 $223,755 - $402,484	-11,516 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	11,516	11,516 $184,000

332

95.3M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $570M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.